New Study Article on Fosamax and Atypical Femur Fractures

Share Article

A new study article published in October 2012 by The Journal of Clinical Endocrinology & Metabolism indicates that atypical femur fractures patients while taking bisphosphonates (incl. Fosamax) experienced delayed healing, prodromal pain, and persisting risk of a contralateral and/or other fracture. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fosamax severe adverse events. [http://www.attorneyone.com/fosamax-lawsuit/

Fosamax: severe adverse events threat

Fosamax: severe adverse events threat

atypical femur fractures patients while taking bisphosphonates (incl. Fosamax) experienced delayed healing, prodromal pain, and persisting risk of a contralateral and/or other fracture

The media spotlight is often a double-edged sword. No one knows this better than people who filed a Fosamax Lawsuit. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

A new study article published in October 2012 by The Journal of Clinical Endocrinology & Metabolism indicates that atypical femur fractures patients while taking bisphosphonates (incl. Fosamax) experienced delayed healing, prodromal pain, and persisting risk of a contralateral and/or other fracture. Fosamax, manufactured by Merck, belongs to the class of drugs known as bisphosphonates. It was approved by the FDA in 1995 and developed to treat post-menopausal osteoporosis and Paget's disease of bone. The authors analyzed the cases of 81 individuals who had incurred one or more atypical femur fractures (AFFs) while taking bisphosphonates for prevention or treatment of osteoporosis collecting long-term histories.

On June 29th, 2012 a South Carolina woman, Selma Wilson, filed a lawsuit in New Jersey District Court (case no. 3:2012cv04014) alleging she suffered femur fracture from her use of Fosamax.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Fosamax, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that the alleged threat from Fosamax remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

A study published online in May 2012, by the Archives of Internal Medicine, a publication of the American Medical Association, revealed that atypical femoral fractures were associated with bisphosphonate (including Fosamax) use.

AttorneyOne.com has further information on Fosamax lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/11/prweb10136765.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Visit website